AU9251801A - Novel compounds - Google Patents

Novel compounds

Info

Publication number
AU9251801A
AU9251801A AU9251801A AU9251801A AU9251801A AU 9251801 A AU9251801 A AU 9251801A AU 9251801 A AU9251801 A AU 9251801A AU 9251801 A AU9251801 A AU 9251801A AU 9251801 A AU9251801 A AU 9251801A
Authority
AU
Australia
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU9251801A
Inventor
Styrbjorn Bystrom
Stephen James
Charlotta Liljebris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biovitrum AB
Original Assignee
Biovitrum AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to SE0003437A priority Critical patent/SE0003437D0/en
Priority to US23889600P priority
Priority to SE0102094A priority patent/SE0102094D0/en
Priority to US30088601P priority
Application filed by Biovitrum AB filed Critical Biovitrum AB
Priority to PCT/SE2001/002149 priority patent/WO2002026707A1/en
Publication of AU9251801A publication Critical patent/AU9251801A/en
Application status is Pending legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/60Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
AU9251801A 2000-09-26 2001-09-26 Novel compounds Pending AU9251801A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE0003437A SE0003437D0 (en) 2000-09-26 2000-09-26 Novel compounds
US23889600P true 2000-10-10 2000-10-10
SE0102094A SE0102094D0 (en) 2001-06-13 2001-06-13 Novel compounds
US30088601P true 2001-06-26 2001-06-26
PCT/SE2001/002149 WO2002026707A1 (en) 2000-09-26 2001-09-26 Novel compounds

Publications (1)

Publication Number Publication Date
AU9251801A true AU9251801A (en) 2002-04-08

Family

ID=27484526

Family Applications (1)

Application Number Title Priority Date Filing Date
AU9251801A Pending AU9251801A (en) 2000-09-26 2001-09-26 Novel compounds

Country Status (2)

Country Link
AU (1) AU9251801A (en)
WO (1) WO2002026707A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005035551A2 (en) 2003-10-08 2005-04-21 Incyte Corporation Inhibitors of proteins that bind phosphorylated molecules
ES2393885T7 (en) 2007-06-04 2014-01-30 Synergy Pharmaceuticals Inc. Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
AU2009256157B2 (en) 2008-06-04 2014-12-18 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
JP5575137B2 (en) 2008-10-22 2014-08-20 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful as antidiabetic agents
WO2010051206A1 (en) 2008-10-31 2010-05-06 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
JP2013520502A (en) 2010-02-25 2013-06-06 メルク・シャープ・エンド・ドーム・コーポレイション Novel cyclic benzimidazole derivatives that are useful anti-diabetic drugs
US9073941B2 (en) 2010-06-28 2015-07-07 Academia Sinica Compounds and methods for treating tuberculosis infection
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN103476258B (en) 2011-02-25 2017-04-26 默沙东公司 Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
US9527875B2 (en) 2012-08-02 2016-12-27 Merck Sharp & Dohme Corp. Antidiabetic tricyclic compounds
US9486433B2 (en) 2012-10-12 2016-11-08 Mochida Pharmaceuticals Co. Ltd. Compositions and methods for treating non-alcoholic steatohepatitis
US10441560B2 (en) 2013-03-15 2019-10-15 Mochida Pharmaceutical Co., Ltd. Compositions and methods for treating non-alcoholic steatohepatitis
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CN105592846A (en) 2013-03-15 2016-05-18 持田制药株式会社 Compositions and methods for treating non-alcoholic steatohepatitis
AU2014235209B2 (en) 2013-03-15 2018-06-14 Synergy Pharmaceuticals Inc. Guanylate cyclase receptor agonists combined with other drugs
EA201592263A1 (en) 2013-06-05 2016-05-31 Синерджи Фармасьютикалз, Инк. Ultrascular agonists of guanylacyclase c, method of their receiving and using
KR20170044197A (en) 2014-08-29 2017-04-24 테스 파마 에스.알.엘. --- inhibitors of -amino--carboxymuconic acid semialdehyde decarboxylase
BR112019007543A2 (en) 2016-10-14 2019-07-02 Tes Pharma S R L alpha-amino-beta-carboximuconic acid inhibitors semialdehyde decarboxylase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4510157A (en) * 1982-12-27 1985-04-09 Ayerst, Mckenna & Harrison, Inc. 6,7,8,9-Tetrahydro-1H-benz(g)indol-8-amine derivatives
HU0101792A3 (en) * 1998-05-12 2003-01-28 Wyeth Corp Benzothiophenes, benzofurans, and indoles, their use for producing medicaments and this medicaments useful in the treatment of insulin resistance and hyperglycemia

Also Published As

Publication number Publication date
WO2002026707A1 (en) 2002-04-04

Similar Documents

Publication Publication Date Title
DZ3293A1 (en) Substituted arylpyrazines
ZA200304133B (en) Novel indanylidene compounds.
GB0105895D0 (en) Novel compounds
PL357565A1 (en) Novel biarylcarboxamides
AU8860401A (en) Novel guanidinobenzamides
PT1310502E (en) Phosphonocephem compound
PL363841A1 (en) Substituted iminoazines
AU6634501A (en) Five-membered-ring compound
AU6508901A (en) Rc-timer scheme
AU2002359165A8 (en) Novel compounds
GB0018528D0 (en) Compounds
GB0007405D0 (en) Compounds
GB0107907D0 (en) Novel compounds
AU2573002A (en) Compounds
EP1333833A4 (en) Novel compounds
GB0024089D0 (en) Novel compounds
GB0003154D0 (en) Novel compounds
AU3847601A (en) Motolide compounds
GB0005357D0 (en) Compounds
AU7476301A (en) Novel compounds
SI1263725T1 (en) Novel compounds
GB0013737D0 (en) Novel compounds
GB0024808D0 (en) Novel compounds
GB0024807D0 (en) Novel compounds
PL358280A1 (en) Novel compounds